{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:10:00Z","timestamp":1723939800000},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,16]]},"DOI":"10.7759\/cureus.67049","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T06:34:22Z","timestamp":1723876462000},"source":"Crossref","is-referenced-by-count":0,"title":["Bacillus Calmette-Gu\u00e9rin (BCG)-Induced Pneumonitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Farrag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhiamluka","family":"Solano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaykumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2342599","article-title":"Understanding and overcoming resistance to immunotherapy in genitourinary cancers","volume":"25","author":"Evans ST","year":"2024","unstructured":"Evans ST, Jani Y, Jansen CS, Yildirim A, Kalemoglu E, Bilen MA. Understanding and overcoming resistance to immunotherapy in genitourinary cancers. Cancer Biol Ther. 2024, 25:2342599. 10.1080\/15384047.2024.2342599","journal-title":"Cancer Biol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03924-3","article-title":"Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study","volume":"56","author":"Brisuda A","year":"2024","unstructured":"Brisuda A, Hor\u0148\u00e1k J, \u017demli\u010dkov\u00e1 B, H\u00e1\u010dek J, Babjuk M. Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study. Int Urol Nephrol. 2024, 56:2243-50. 10.1007\/s11255-023-03924-3","journal-title":"Int Urol Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/BF00205239","article-title":"Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Gu\u00e9rin","volume":"28","author":"van der Meijden AP","year":"1989","unstructured":"van der Meijden AP, Steerenberg PA, van Hoogstraaten IM, et al.. Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Gu\u00e9rin. Cancer Immunol Immunother. 1989, 28:287-95. 10.1007\/BF00205239","journal-title":"Cancer Immunol Immunother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050439","article-title":"Bacillus Calmette-Gu\u00e9rin immunotherapy for cancer","volume":"9","author":"Cardillo F","year":"2021","unstructured":"Cardillo F, Bonfim M, da Silva Vasconcelos Sousa P, Mengel J, Ribeiro Castello-Branco LR, Pinho RT. Bacillus Calmette-Gu\u00e9rin immunotherapy for cancer. Vaccines (Basel). 2021, 9:439. 10.3390\/vaccines9050439","journal-title":"Vaccines (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.07.021","article-title":"Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG","volume":"65","author":"Brausi M","year":"2014","unstructured":"Brausi M, Oddens J, Sylvester R, et al.. Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol. 2014, 65:69-76. 10.1016\/j.eururo.2013.07.021","journal-title":"Eur Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2020.100149","article-title":"Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) treatment's severe complications: a single institution review of incidence, presentation and treatment outcome","volume":"19","author":"Waked R","year":"2020","unstructured":"Waked R, Choucair J, Chehata N, Haddad E, Saliba G. Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) treatment's severe complications: a single institution review of incidence, presentation and treatment outcome. J Clin Tuberc Other Mycobact Dis. 2020, 19:100149. 10.1016\/j.jctube.2020.100149","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm DL","year":"1992","unstructured":"Lamm DL, van der Meijden PM, Morales A, et al.. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992, 147:596-600. 10.1016\/s0022-5347(17)37316-0","journal-title":"J Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.1411","article-title":"Complications of intravesical bacillus calmette-gu\u00e9rin","volume":"8","author":"Macleod LC","year":"2014","unstructured":"Macleod LC, Ngo TC, Gonzalgo ML. Complications of intravesical bacillus calmette-gu\u00e9rin. Can Urol Assoc J. 2014, 8:E540-4. 10.5489\/cuaj.1411","journal-title":"Can Urol Assoc J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05396-7","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review","volume":"20","author":"Shimizu G","year":"2020","unstructured":"Shimizu G, Amano R, Nakamura I, Wada A, Kitagawa M, Toru S. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review. BMC Infect Dis. 2020, 20:708. 10.1186\/s12879-020-05396-7","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000052381","article-title":"BCG intravesical instillations: recommendations for side-effects management","volume":"37","author":"Rischmann P","year":"2000","unstructured":"Rischmann P, Desgrandchamps F, Malavaud B, Chopin DK. BCG intravesical instillations: recommendations for side-effects management. Eur Urol. 2000, 37:33-6. 10.1159\/000052381","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-35","article-title":"BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6","volume":"14","author":"Tobiume M","year":"2014","unstructured":"Tobiume M, Shinohara T, Kuno T, Mukai S, Naruse K, Hatakeyama N, Ogushi F. BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6. BMC Pulm Med. 2014, 14:35. 10.1186\/1471-2466-14-35","journal-title":"BMC Pulm Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18683\/germs.2023.1395","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection presenting as severe respiratory failure and septic shock","volume":"13","author":"Marouli D","year":"2023","unstructured":"Marouli D, Pappas C, Raissaki M, Proklou A, Papadakis E, Kondili E. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection presenting as severe respiratory failure and septic shock. Germs. 2023, 13:277-81. 10.18683\/germs.2023.1395","journal-title":"Germs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/285101-bacillus-calmette-gurin-bcg-induced-pneumonitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T06:34:26Z","timestamp":1723876466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/285101-bacillus-calmette-gurin-bcg-induced-pneumonitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.67049","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}